Friday, March 18, 2016, 69 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $197.20 to $47,685,000.00.

Highlighted Stocks Traded by Insiders:

TeleTech Holdings (TTEC) - FREE Research Report

Barlett James E, who is Vice Chairman at TeleTech Holdings, sold 42,832 shares at $26.72 on March 18, 2016. Following this transaction, the Vice Chairman owned 456,966 shares meaning that the stake was reduced by 8.57% with the 42,832-share transaction.

The shares most recently traded at $27.13, up $0.41, or 1.52% since the insider transaction. Historical insider transactions for TeleTech Holdings go as follows:

  • 4-Week # shares sold: 15,000
  • 12-Week # shares sold: 15,000
  • 24-Week # shares sold: 15,000

The average volume for TeleTech Holdings has been 97,700 shares per day over the past 30 days. TeleTech Holdings has a market cap of $1.3 billion and is part of the services sector and diversified services industry. Shares are down 2.11% year-to-date as of the close of trading on Friday.

TeleTech Holdings, Inc. provides customer engagement management solutions in the United States, the Philippines, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Canada. The stock currently has a dividend yield of 1.34%. The company has a P/E ratio of 21.7. Currently, there are 2 analysts who rate TeleTech Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TTEC - FREE

TheStreet Quant Ratings rates TeleTech Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and solid stock price performance. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full TeleTech Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AmeriServ Financial (ASRV) - FREE Research Report

Wise Robert L, who is Director at AmeriServ Financial, bought 219 shares at $3.14 on March 18, 2016. Following this transaction, the Director owned 124,162 shares meaning that the stake was boosted by 0.18% with the 219-share transaction.

The shares most recently traded at $3.02, down $0.12, or 3.97% since the insider transaction. Historical insider transactions for AmeriServ Financial go as follows:

  • 4-Week # shares bought: 1,000
  • 12-Week # shares bought: 1,442
  • 24-Week # shares bought: 2,072

The average volume for AmeriServ Financial has been 26,100 shares per day over the past 30 days. AmeriServ Financial has a market cap of $57.6 million and is part of the financial sector and banking industry. Shares are down 6.25% year-to-date as of the close of trading on Friday.

AmeriServ Financial, Inc operates as the bank holding company for AmeriServ Financial Bank that provides various consumer, mortgage, and commercial financial products. The stock currently has a dividend yield of 1.31%. The company has a P/E ratio of 9.8.

Exclusive Offer: Get the latest Stock Analysis on ASRV - FREE

TheStreet Quant Ratings rates AmeriServ Financial as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels and compelling growth in net income. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full AmeriServ Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mylan (MYL) - FREE Research Report

Parrish Mark W, who is Director at Mylan, bought 1,705 shares at $44.00 on March 18, 2016. Following this transaction, the Director owned 31,365 shares meaning that the stake was boosted by 5.75% with the 1,705-share transaction.

The shares most recently traded at $45.56, up $1.56, or 3.42% since the insider transaction. Historical insider transactions for Mylan go as follows:

  • 4-Week # shares bought: 4,377
  • 4-Week # shares sold: 34,579
  • 12-Week # shares bought: 15,377
  • 12-Week # shares sold: 34,579
  • 24-Week # shares bought: 15,377
  • 24-Week # shares sold: 34,579

The average volume for Mylan has been 6.0 million shares per day over the past 30 days. Mylan has a market cap of $21.7 billion and is part of the health care sector and drugs industry. Shares are down 16.72% year-to-date as of the close of trading on Friday.

Mylan N.V., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company has a P/E ratio of 38.1. Currently, there are 5 analysts who rate Mylan a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MYL - FREE

TheStreet Quant Ratings rates Mylan as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Mylan Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.